NFFinder: an online bioinformatics tool for searching similar transcriptomics experiments in the context of drug repositioning

Drug repositioning, using known drugs for treating conditions different from those the drug was originally designed to treat, is an important drug discovery tool that allows for a faster and cheaper development process by using drugs that are already approved or in an advanced trial stage for another purpose. This is especially relevant for orphan diseases because they affect too few people to make drug research de novo economically viable. In this paper we present NFFinder, a bioinformatics tool for identifying potential useful drugs in the context of orphan diseases. NFFinder uses transcriptomic data to find relationships between drugs, diseases and a phenotype of interest, as well as identifying experts having published on that domain. The application shows in a dashboard a series of graphics and tables designed to help researchers formulate repositioning hypotheses and identify potential biological relationships between drugs and diseases. NFFinder is freely available at http://nffinder.cnb.csic.es.

[1]  Chi-Ying F. Huang,et al.  miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..

[2]  Rameen Beroukhim,et al.  Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study , 2014, Journal of Neuro-Oncology.

[3]  R. García-Becerra,et al.  Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  J. Kolesar,et al.  Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[5]  Donald J Buchsbaum,et al.  Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. , 2014, Cancer letters.

[6]  A. Hatzigeorgiou,et al.  TarBase: A comprehensive database of experimentally supported animal microRNA targets. , 2005, RNA.

[7]  Stephen P. H. Alexander,et al.  A potential role for cannabinoid receptors in the therapeutic action of fenofibrate , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Hossein Fallahi,et al.  Inhibitory effect of ibuprofen on tumor survival and angiogenesis in gastric cancer cell , 2015, Tumor Biology.

[9]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[10]  Alan Cantor,et al.  Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study. , 2015, Neuro-oncology.

[11]  Jae Yong Cho,et al.  Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer , 2011, PloS one.

[12]  Michael A. Tainsky,et al.  RAS/MEK–Independent Gene Expression Reveals BMP2-Related Malignant Phenotypes in the Nf1-Deficient MPNST , 2013, Molecular Cancer Research.

[13]  G. Hong,et al.  Nucleic Acids Research , 2015, Nucleic Acids Research.

[14]  Devarajan Karunagaran,et al.  Menadione (Vitamin K3) induces apoptosis of human oral cancer cells and reduces their metastatic potential by modulating the expression of epithelial to mesenchymal transition markers and inhibiting migration. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[15]  Joel Dudley,et al.  Exploiting drug-disease relationships for computational drug repositioning , 2011, Briefings Bioinform..

[16]  Robert Petryszak,et al.  ArrayExpress update—simplifying data submissions , 2014, Nucleic Acids Res..

[17]  Lu Zhang,et al.  The effects of antiepileptic drug valproic acid on apoptosis of hippocampal neurons in epileptic rats. , 2015, Pakistan journal of pharmaceutical sciences.

[18]  Li Li,et al.  The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer , 2013, PloS one.

[19]  Diogo R Lara,et al.  A clinical trial of adjuvant allopurinol therapy for moderately refractory schizophrenia. , 2005, The Journal of clinical psychiatry.

[20]  Jamie L Johnson,et al.  Pyoderma Gangrenosum Associated with an Aseptic Splenic Abscess in a Patient with Neurofibromatosis , 2015, Pediatric dermatology.

[21]  Stefan Leucht,et al.  Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. , 2014, The Cochrane database of systematic reviews.

[22]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[23]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. R. Pena,et al.  Anisomycin administered in the olfactory bulb and dorsal hippocampus impaired social recognition memory consolidation in different time-points , 2014, Brain Research Bulletin.

[25]  Gwan-Su Yi,et al.  Drug Similarity Search Based on Combined Signatures in Gene Expression Profiles , 2014, Healthcare informatics research.

[26]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[27]  Francisco Tirado,et al.  MARQ: an online tool to mine GEO for experiments with similar or opposite gene expression signatures , 2010, Nucleic Acids Res..

[28]  Caterina Giannini,et al.  Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study. , 2012, Neuro-oncology.

[29]  Jitamanyu Chakrabarty,et al.  Development and Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Phenoxyethanol, Methylparaben, Propylparaben, Mometasone Furoate, and Tazarotene in Topical Pharmaceutical Dosage Formulation , 2013, Scientia pharmaceutica.

[30]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[31]  Alan R. Aronson,et al.  An overview of MetaMap: historical perspective and recent advances , 2010, J. Am. Medical Informatics Assoc..

[32]  Andreas Engert,et al.  Soluble Tissue Factor Induces Coagulation on Tumor Endothelial Cells In Vivo if Coadministered With Low-Dose Lipopolysaccharides , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[33]  Kyoung Mii Park,et al.  CDA: Combinatorial Drug Discovery Using Transcriptional Response Modules , 2012, PloS one.

[34]  Dietrich Büsselberg,et al.  Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects , 2011, Cancers.

[35]  M Caine,et al.  A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. 1978. , 2002, The Journal of urology.

[36]  U. Naumann,et al.  The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells. , 2013, Anticancer research.

[37]  M. Webber,et al.  Cholecalciferol (Vitamin D3) Inhibits Growth and Invasion by Up-regulating Nuclear Receptors and 25-Hydroxylase (CYP27A1) in Human Prostate Cancer Cells , 2005, Clinical & Experimental Metastasis.

[38]  Sean Ekins,et al.  In silico repositioning of approved drugs for rare and neglected diseases. , 2011, Drug discovery today.

[39]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[40]  Krister Wennerberg,et al.  Identification of structural features in chemicals associated with cancer drug response: a systematic data-driven analysis , 2013, Bioinform..

[41]  B. Elewski,et al.  A randomized, double-blinded trial evaluating the efficacy and tolerability of vectical ointment (calcitriol 3 mcg/g ointment) when compared to betamethasone diproprionate ointment (64 mg/g) in patients with nail psoriasis. , 2014, Journal of drugs in dermatology : JDD.

[42]  Satoshi Takamatsu,et al.  Antiparasitic alkaloids from Psychotria klugii. , 2003, Journal of natural products.

[43]  S. Meretyk,et al.  A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. , 1978, British journal of urology.

[44]  Jin Dai,et al.  Atypical, but Not Typical, Antipsychotic Drugs Increase Cortical Acetylcholine Release without an Effect in the Nucleus Accumbens or Striatum , 2002, Neuropsychopharmacology.

[45]  B. Trink,et al.  Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells , 2012, Apoptosis.

[46]  Jie Li,et al.  Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways , 2014, PloS one.

[47]  Liang Ming,et al.  Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines. , 2015, Molecular medicine reports.

[48]  M. Fielden,et al.  Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. , 2005, Journal of biotechnology.

[49]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[50]  Mario Medvedovic,et al.  Generalized random set framework for functional enrichment analysis using primary genomics datasets , 2011, Bioinform..

[51]  Gilbert Vezina,et al.  Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  S. Chiou,et al.  Indomethacin promotes apoptosis in gastric cancer cells through concomitant degradation of Survivin and Aurora B kinase proteins , 2014, Apoptosis.

[53]  Michael Platten,et al.  Treatment of anaplastic glioma. , 2015, Cancer treatment and research.

[54]  A. Varan,et al.  Diencephalic tumors in children: a 30-year experience of a single institution , 2011, Child's Nervous System.

[55]  M. Perreault,et al.  Systematic Review of Antipsychotics for the Treatment of Hospital-Associated Delirium in Medically or Surgically III Patients , 2006, The Annals of pharmacotherapy.

[56]  Yunshan Wang,et al.  Activation of the intrinsic apoptosis pathway contributes to the induction of apoptosis in hepatocellular carcinoma cells by valproic acid , 2014, Oncology letters.

[57]  Ning Liu,et al.  Fenofibrate induces G0/G1 phase arrest by modulating the PPARα/FoxO1/p27kip pathway in human glioblastoma cells , 2015, Tumor Biology.

[58]  M. Irshad,et al.  Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines , 2015, Pharmaceutical biology.

[59]  Michael A Babcock,et al.  Neurofibromatosis Type 1 Revisited , 2009, Pediatrics.

[60]  Adam C. Gower,et al.  Discovering biological connections between experimental conditions based on common patterns of differential gene expression , 2011, BMC Bioinformatics.

[61]  Tianhong Li,et al.  The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and Cetuximab , 2011, Clinical Cancer Research.

[62]  K. Urabe,et al.  Vitamin D3 analogues improve café au lait spots in patients with von Recklinghausen's disease: experimental and clinical studies. , 1999, European journal of dermatology : EJD.

[63]  Shadi Dalili,et al.  Benzethonium Chloride: A Novel Anticancer Agent Identified by Using a Cell-Based Small-Molecule Screen , 2006, Clinical Cancer Research.

[64]  T. Slaga,et al.  Fluocinolone acetonide: a potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesis. , 1977, Chemico-biological interactions.

[65]  Jing Liu,et al.  In vitro and in vivo evaluation of anisomycin against Ehrlich ascites carcinoma. , 2013, Oncology reports.

[66]  C. James,et al.  Reduced Phosphocholine and Hyperpolarized Lactate Provide Magnetic Resonance Biomarkers of Pi3k/akt/mtor Inhibition in Glioblastoma Neuro-onco Lo Gy , 2022 .

[67]  Laura F Sandoval,et al.  Adherence to a five day treatment course of topical fluocinonide 0.1% cream in atopic dermatitis. , 2013, Dermatology online journal.

[68]  C. Rudin,et al.  Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis. , 2015, Neuro-oncology.

[69]  Sean R. Davis,et al.  GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor , 2007, Bioinform..

[70]  A. Andea,et al.  Sirolimus-associated regression of benign lymphangioendothelioma. , 2014, Journal of the American Academy of Dermatology.

[71]  Eric Legius,et al.  PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies , 2014, Nature.

[72]  P S Harper,et al.  Molecular genetics of neurofibromatosis type 1 (NF1). , 1996, Journal of medical genetics.